Evidence map›Paper›PMID 42469517›Full record

ArticleJournal of cancer survivorship : research and practice2026

Are age and sex associated with variation in use of follow-up care and financial barriers to care in U.S. cancer survivors?

Gracie E Himmelstein, Patricia A Ganz

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gracie E HimmelsteinDivision of Hematology and Oncology, Department of Medicine, UCLA Health, Los Angeles, CA, USA. ghimmelstein@mednet.ucla.edu.ORCID https://orcid.org/0000-0002-6687-8102
Patricia A GanzDivision of Hematology and Oncology, Department of Medicine, UCLA Health, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLong-term follow-up of cancer survivors is essential. How prevalent are lack of adequate follow-up and financial barriers to care among U.S. cancer survivors, and how does this vary by patients' demographic characteristics?

methodsWe analyzed data from the 2019-2024 National Health Interview Survey. Among adults age 18+ , we identified 23,142 reporting ever receiving a cancer diagnosis. We assessed indicators of inadequate follow-up care and financial barriers to care. We performed multivariable logistic regression to assess demographic characteristics associated with inadequate follow-up and financial barriers.

resultsOverall, 10.4% of survivors had inadequate follow-up, and 10.9% reported financial barriers to care. Higher rates were observed among younger (age 18-44) survivors, 22.9% of whom had inadequate follow-up (p < 0.001), and 21.0% of whom reported a financial barrier (p < 0.0001). While younger men (vs. women) 18-44 had higher odds of inadequate follow-up (aOR 1.82, 95% CI 1.32-2.51), male survivors overall had lower adjusted odds of financial barriers (aOR 0.70, 95% I 0.69-0.79).

conclusionsOver one in ten U.S. adult cancer survivors - and more than one in five younger adults with a cancer history - lack adequate follow-up care and face financial barriers to care. Although younger men were particularly likely to have inadequate follow-up, men faced fewer financial barriers. IMPLICATIONS FOR CANCER SURVIVORS: Millions of U.S. cancer survivors receive inadequate follow-up and face financial barriers to care. Ongoing efforts to keep survivors engaged in care, and research to further elucidate barriers to care, are essential for providing high-quality care to cancer survivors.

Indexed as

Financial barriersFollow-up careSurvivorship careYoung-adult survivors

Identifiers

PMID42469517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.